Dr. Mansha Grover is a highly qualified Pulmonologist in Bangalore with expertise in diagnosing and treating respiratory diseases, lung disorders, and critical care conditions. She is experienced in managing asthma, COPD, tuberculosis, lung infections, and interstitial lung diseases, with a strong focus on evidence-based and patient-centered care.
With advanced training in pulmonary medicine and critical care, Dr. Mansha Grover is committed to providing accurate diagnosis and effective treatment for a wide range of acute and chronic respiratory conditions.
Pulmonology
Female
Over 7+ years of Pulmonology experience
Qualifications : MD – Respiratory Medicine
MBBS – Bachelor of Medicine & Bachelor of Surgery
Specialty : Pulmonology
Experience :
Consultant Pulmonologist – Extensive experience in treating respiratory and lung disorders
Experience in critical care and ICU management
Managed patients with chronic lung diseases and acute respiratory emergencies
Asthma Management
Chronic Obstructive Pulmonary Disease (COPD)
Tuberculosis (TB) Treatment
Lung Infections & Pneumonia
Interstitial Lung Disease (ILD)
Bronchoscopy Procedures
Sleep-Related Breathing Disorders
Critical Care & ICU Management
Advanced Pulmonary Diagnostics
Patient-Centered Treatment Approach
Critical Care Expertise
Strong Clinical Decision-Making
• AIIMS PULMOCRIT-2025, participated as delegate and presented a poster on clinicoradiological and demographic profile in lung
carcinoma patients and role of passive smoking in lung cancer patients.
• CME 11 August 2025 hosted by CLIRNET awarded certificate on pulmonary embolism in pregnancy
• MEDICON 2024, conducted hands-on session on Cryotherapy, Cryo-foreign body removal and Cryo-Biopsy
• RAJPULMOCON 2022: Rajasthan state pulmonologists annual meet hosted at RNT, UDAIPUR
• AIIMS RAJKOT 31 JULY 2022: Workshop on pulmonary manifestation of connective tissue disorder
• NAPCON 2021, Varanasi: OSCE (objective structured clinical examination) and mock PG practical
• NAPCON 2020: Workshop on bronchoscopy, organized by NCCP and ICS
• To study the efficacy of H mono poly regimen and pattern of drug resistance in treatment failure cases: IJNRD2302281
• To study the correlation between smoking and CTSS in covid 19 RTPCR positive patients: IJCR 31.01.2022
• To study the clinic- radiological profile and progression of disease in patients of interstitial lung disease: Pariprex Journal of
research.DOI:10.36106
• To study the correlation of CT severity score and oxygen saturation and inflammatory biomarkers: ISSN no:25456-2165
